Lexeo Therapeutics (LXEO) Change in Cash (2022 - 2026)
Lexeo Therapeutics recorded quarterly Change in Cash of $8.8 million in Q1 2026, down 60.15% quarter-over-quarter from $22.0 million in Q4 2025, and up 243.62% year-over-year from $2.6 million in Q1 2025.
Lexeo Therapeutics' Change in Cash history runs 5 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Change in Cash rose 243.62% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $42.9 million (up 125.79% YoY), while the FY2025 annual figure was $28.0 million, up 132.37% from the prior year.
- Change in Cash came in at $8.8 million for Q1 2026 at Lexeo Therapeutics, down from $22.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $86.0 million in Q4 2023 to a low of -$122.0 million in Q4 2024.
- A 5-year average of -$1.6 million and a median of -$8.1 million in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash surged 611.58% in 2023 and plunged 241.84% in 2024, its largest moves.
- Lexeo Therapeutics' Change in Cash stood at -$16.8 million in 2022, then soared by 611.58% to $86.0 million in 2023, then slumped by 241.84% to -$122.0 million in 2024, then soared by 118.04% to $22.0 million in 2025, then plunged by 60.15% to $8.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $8.8 million, $22.0 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | 8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.77 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Dec 31, 2024 | -122.01 Mn |
| Sep 30, 2024 | -17.96 Mn |
| Jun 30, 2024 | -20.08 Mn |
| Mar 31, 2024 | 73.59 Mn |
| Dec 31, 2023 | 86.02 Mn |
| Sep 30, 2023 | -10.09 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -18.47 Mn |
| Dec 31, 2022 | -16.81 Mn |